glp 1 weight loss clinical trials Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment GLP-1s like Ozempic are among

Elevated TMAO levels in patients with coronary artery disease (CAD) are linked to a higher atherosclerotic load as measured by Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) scores

The contribution of mast cells to autoimmune brain disorders is not merely theoretical

The transfer of iron from enterocytes to the blood occurs via ferroportin, which is downregulated via hepcidin, a liver-derived hormone (Ginzburg 2019)

Access to Specialized Medications We connect patients with providers who can prescribe various options, including compounded semaglutide or compounded tirzepatide